WhiteLab Genomics
Unleash the potential of genomic medicine using AI
WhiteLab Genomics is a TechBio company using artificial intelligence to design the building blocks of genomic medicines. Its proprietary ALFRED platform designs viral and non-viral delivery vehicles and programmable genetic payloads, which are then experimentally validated and tested in vivo to identify candidates with the properties required for therapeutic development. Through this integrated approach, WhiteLab Genomics is building a portfolio of validated bio-assets that it advances independently and with pharmaceutical and biotechnology partners developing the next generation of genomic medicines. Founded in 2019, WhiteLab works with industrial and academic partners including Sanofi, Cytiva, the University of Massachusetts, the Vision Institute in Paris and the Paris Brain Institute, alongside additional collaborations with biotechnology companies. The company is part of Y-Combinator, Station F and Future4Care and is a French Tech 2030 laureate. WhiteLab Genomics operates from Paris, Boston, and Montreal.
- Website
- whitelabgx.com
- City
- Paris
- Country
- France
- YC batch
- Winter 2022
- Team
- 52 people
- Stage
- Growth stage
- AI-native
- Yes
More Health & bio in Paris
Doctolib$6.2bn
Appointment booking and software for clinicians.
Alan$1.68bn
Health technology. Valued at $1.68bn (April 2021).
Dental Monitoring$1.2bn
Healthcare. Valued at $1.2bn (October 2021).
LucisHiring
Function Health for Europe
Parallel
AI agents for healthcare admin
BioSerenity
French healthcare company.
Claim this profile
Free and instant: prove you run whitelabgx.com and edit the profile yourself.
- Your logo, office address and founder photos
- The ✓ Verified mark next to WhiteLab Genomics across the site
- Open roles listed on the Hiring board
- A followed link back to your website
A rank card with WhiteLab Genomics's standing on Labspie, or a simple badge. Both link to this profile and update themselves.
